Last 12 months
Inside the activity.
16 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 7 | 0 |
| Apr 2026 | 1 | 2 |
| May 2026 | 3 | 0 |
| Jun 2026 | 2 | 1 |
| Jul 2026 | 2 | 2 |
| Aug 2026 | 1 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2023 Filed Nov 15, 2023 23:49 UTC |
Hively BradDirector
|
Disposition to issuerCommon stock | 27,117 | $2.39 | $64,755.40 |
DisclosureSEC source: 0001628280-23-039192 · wk-form4_1700092157.xml · nonDerivative · entry 3 Hively Brad · CIK 0001891124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,065 Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:40 UTC |
Podnos YaleChief Medical Officer
|
Disposition to issuerCommon stock | 1,860 | $2.39 | $4,436.10 |
DisclosureSEC source: 0001628280-23-039321 · wk-form4_1700170789.xml · nonDerivative · entry 2 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,368 Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:40 UTC |
Podnos YaleChief Medical Officer
|
Disposition to issuerCommon stock | 238 | $2.39 | $567.87 |
DisclosureSEC source: 0001628280-23-039321 · wk-form4_1700170789.xml · nonDerivative · entry 1 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,228 Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 20:56 UTC |
Virnich DanielChief Executive Officer
|
Disposition to issuerCommon stock | 4,604 | $2.39 | $10,980.54 |
DisclosureSEC source: 0001628280-23-039300 · wk-form4_1700168164.xml · nonDerivative · entry 1 Virnich Daniel · CIK 0001891107 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 733,925 Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:49 UTC |
Hively BradDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 47,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001628280-23-039192 · wk-form4_1700092157.xml · derivative · entry 4 Hively Brad · CIK 0001891124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,770,431 Underlying: Common stock · 47,000 shares Expires 2029-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of December 2, 2019 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:49 UTC |
Hively BradDirector
|
SaleCommon stock | 47,000 | $2.52 | $118,581.00 |
DisclosureSEC source: 0001628280-23-039192 · wk-form4_1700092157.xml · nonDerivative · entry 2 Hively Brad · CIK 0001891124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 724,182 Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:49 UTC |
Hively BradDirector
|
Exercise / conversionCommon stock | 47,000 | $0.85 | $39,950.00 |
DisclosureSEC source: 0001628280-23-039192 · wk-form4_1700092157.xml · nonDerivative · entry 1 Hively Brad · CIK 0001891124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 771,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2023 Filed May 25, 2023 00:43 UTC |
Shah MihirChief Financial Officer
|
Disposition to issuerCommon Stock | 869 | $0.43 | $371.93 |
DisclosureSEC source: 0001799191-23-000008 · edgardoc.xml · nonDerivative · entry 2 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,472 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on May 23, 2023 within a one-dollar range. Actual prices ranged from $0.4201 to $0.4600. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2023 Filed May 25, 2023 00:43 UTC |
Shah MihirChief Financial Officer
|
Disposition to issuerCommon Stock | 2,573 | $0.43 | $1,101.24 |
DisclosureSEC source: 0001799191-23-000008 · edgardoc.xml · nonDerivative · entry 1 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,341 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on May 23, 2023 within a one-dollar range. Actual prices ranged from $0.4201 to $0.4600. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 10,000 | $0.55 | $5,500.00 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 8 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,193 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 10,000 | $0.55 | $5,500.00 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 7 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,193 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 2,146 | $0.55 | $1,176.01 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 6 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,193 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 7,654 | $0.55 | $4,209.70 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 5 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,047 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 9,948 | $0.55 | $5,471.40 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 4 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,393 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 200 | $0.55 | $109.60 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 3 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,445 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 52 | $0.55 | $28.55 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,245 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:01 UTC |
BARASCH RICHARD ADirector
|
PurchaseCommon stock | 10,000 | $0.55 | $5,500.00 |
DisclosureSEC source: 0001628280-23-008836 · wf-form4_167944686729240.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,193 Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:06 UTC |
Kaushal MohitDirector
|
GrantCommon stock | 19,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008838 · wf-form4_167944717325553.xml · nonDerivative · entry 1 Kaushal Mohit · CIK 0001683021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,393 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:04 UTC |
Podnos YaleChief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 83,047 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001628280-23-008837 · wf-form4_167944702947968.xml · derivative · entry 2 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,047 Underlying: Common stock · 83,047 shares Expires 2033-03-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:04 UTC |
Podnos YaleChief Medical Officer
|
GrantCommon stock | 33,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008837 · wf-form4_167944702947968.xml · nonDerivative · entry 1 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,466 F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:00 UTC |
Shah MihirChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 440,477 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001628280-23-008833 · wf-form4_167944679255330.xml · derivative · entry 2 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,477 Underlying: Common stock · 440,477 shares Expires 2033-03-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:00 UTC |
Shah MihirChief Financial Officer
|
GrantCommon stock | 176,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008833 · wf-form4_167944679255330.xml · nonDerivative · entry 1 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,914 F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:56 UTC |
Miller Matthew PChief Operating Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 169,169 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001628280-23-008832 · wf-form4_167944655124135.xml · derivative · entry 2 Miller Matthew P · CIK 0001915822 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,169 Underlying: Common stock · 169,169 shares Expires 2033-03-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:56 UTC |
Miller Matthew PChief Operating Officer
|
GrantCommon stock | 67,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008832 · wf-form4_167944655124135.xml · nonDerivative · entry 1 Miller Matthew P · CIK 0001915822 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,992 F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:52 UTC |
SARIN RAVI YANGDirector
|
GrantCommon stock | 29,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008831 · wf-form4_167944632508935.xml · nonDerivative · entry 1 SARIN RAVI YANG · CIK 0001555959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,427 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:50 UTC |
Virnich DanielPresident
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 287,361 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001628280-23-008830 · wf-form4_167944622505473.xml · derivative · entry 2 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,361 Underlying: Common stock · 287,361 shares Expires 2033-03-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:50 UTC |
Virnich DanielPresident
|
GrantCommon stock | 114,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008830 · wf-form4_167944622505473.xml · nonDerivative · entry 1 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 738,529 F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:49 UTC |
O'Meara MaeveDirector
|
GrantCommon stock | 16,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008829 · wf-form4_167944617091630.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,104 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:47 UTC |
McGeorge AnneDirector
|
GrantCommon stock | 26,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008828 · wf-form4_167944604001492.xml · nonDerivative · entry 1 McGeorge Anne · CIK 0001779934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,346 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:46 UTC |
Pacala Mark LDirector
|
GrantCommon stock | 6,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008827 · wf-form4_167944596405529.xml · nonDerivative · entry 1 Pacala Mark L · CIK 0001321250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,399 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:45 UTC |
Johnson Karen MarieDirector
|
GrantCommon stock | 19,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008826 · wf-form4_167944590432914.xml · nonDerivative · entry 1 Johnson Karen Marie · CIK 0001892819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,185 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:44 UTC |
Hively BradDirector · Chief Executive Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 421,280 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001628280-23-008825 · wf-form4_167944585635107.xml · derivative · entry 2 Hively Brad · CIK 0001891124 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,280 Underlying: Common stock · 421,280 shares Expires 2033-03-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:44 UTC |
Hively BradDirector · Chief Executive Officer
|
GrantCommon stock | 168,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008825 · wf-form4_167944585635107.xml · nonDerivative · entry 1 Hively Brad · CIK 0001891124 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 724,182 F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. F1 · price: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| December 16, 2022 Filed Dec 21, 2022 01:07 UTC |
Miller Matthew PChief Operating Officer
|
PurchaseCommon Stock | 73,684 | $0.95 | $69,999.80 |
DisclosureSEC source: 0001799191-22-000058 · edgardoc.xml · nonDerivative · entry 1 Miller Matthew P · CIK 0001915822 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,325 F1 · shares: The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b). Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:02 UTC |
Virnich DanielPresident
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001799191-22-000056 · edgardoc.xml · derivative · entry 4 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,609 Underlying: Common Stock · 175,000 shares Expires 2030-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:02 UTC |
Virnich DanielPresident
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001799191-22-000056 · edgardoc.xml · derivative · entry 3 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829,609 Underlying: Common Stock · 175,000 shares Expires 2030-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:02 UTC |
Virnich DanielPresident
|
Exercise / conversionCommon Stock | 175,000 | $0.86 | $150,500.00 |
DisclosureSEC source: 0001799191-22-000056 · edgardoc.xml · nonDerivative · entry 2 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:02 UTC |
Virnich DanielPresident
|
Exercise / conversionCommon Stock | 175,000 | $0.86 | $150,500.00 |
DisclosureSEC source: 0001799191-22-000056 · edgardoc.xml · nonDerivative · entry 1 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 17:31 UTC |
BARASCH RICHARD ADirector
|
GrantCommon Stock | 22,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000031 · edgardoc.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,727 F1 · price: Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 17:32 UTC |
Ling GabrielDirector
|
GrantCommon Stock | 29,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000035 · edgardoc.xml · nonDerivative · entry 1 Ling Gabriel · CIK 0001945281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,057 F1 · price: Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:36 UTC |
Virnich DanielPresident
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 203,543 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001799191-22-000044 · edgardoc.xml · derivative · entry 2 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,543 Underlying: Common Stock · 203,543 shares Expires 2032-11-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:36 UTC |
Virnich DanielPresident
|
GrantCommon Stock | 40,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000044 · edgardoc.xml · nonDerivative · entry 1 Virnich Daniel · CIK 0001891107 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,585 F1 · price: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:36 UTC |
Simoneit DionaChief Accounting Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 52,722 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001799191-22-000043 · edgardoc.xml · derivative · entry 2 Simoneit Diona · CIK 0001921432 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,722 Underlying: Common Stock · 52,722 shares Expires 2032-11-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:36 UTC |
Simoneit DionaChief Accounting Officer
|
GrantCommon Stock | 10,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000043 · edgardoc.xml · nonDerivative · entry 1 Simoneit Diona · CIK 0001921432 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,705 F1 · price: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:35 UTC |
Shah MihirChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 94,418 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001799191-22-000042 · edgardoc.xml · derivative · entry 2 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,418 Underlying: Common Stock · 94,418 shares Expires 2032-11-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:35 UTC |
Shah MihirChief Financial Officer
|
GrantCommon Stock | 18,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000042 · edgardoc.xml · nonDerivative · entry 1 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,723 F1 · price: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:35 UTC |
SARIN RAVI YANGDirector
|
GrantCommon Stock | 22,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000041 · edgardoc.xml · nonDerivative · entry 1 SARIN RAVI YANG · CIK 0001555959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,899 F1 · price: Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:34 UTC |
Podnos YaleChief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 71,895 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001799191-22-000040 · edgardoc.xml · derivative · entry 2 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,895 Underlying: Common Stock · 71,895 shares Expires 2032-11-17 F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:34 UTC |
Podnos YaleChief Medical Officer
|
GrantCommon Stock | 14,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000040 · edgardoc.xml · nonDerivative · entry 1 Podnos Yale · CIK 0001891104 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,247 F1 · price: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:34 UTC |
Pacala Mark LDirector
|
GrantCommon Stock | 29,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001799191-22-000039 · edgardoc.xml · nonDerivative · entry 2 Pacala Mark L · CIK 0001321250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,837 F1 · price: Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.